SUPPORT FOR YOU AND YOUR PRACTICE IS JUST A CLICK AWAY
Several resources are available below to help you and your patients with suspected or diagnosed cerebrotendinous xanthomatosis (CTX).
*GeneReviews CTX: The National Institutes of Health maintains GeneReviews—expert-authored, peer-reviewed disease descriptions ("chapters") presented in a standardized format and focused on clinically relevant and medically actionable information on the diagnosis, management, and genetic counseling of patients and families with genetic conditions, including CTX.
*Genetic testing registry (GTR): The National Institutes of Health maintains a database of available tests for CTX and other genetic conditions.
*National Organization for Rare Disorders (NORD) CTX: NORD is a patient advocacy organization dedicated to individuals with rare diseases and the organizations that serve them.
*National Institutes of Health – Genetic and Rare Diseases Information Center: Find additional information on CTX on this page, hosted by the US Department of Health and Human Services.
About CTX.com/patient: See the patient/caregiver section of this site for resources and information tailored to those who have a family member with a possible or confirmed diagnosis of CTX.
*United Leukodystrophy Foundation: CTX is sometimes characterized as a leukodystrophy. The United Leukodystrophy Foundation maintains a CTX page and has a discussion forum where patients with CTX and their families can connect and offer support.
*Note that Mirum Pharmaceuticals, Inc., cites the above-named external resources for information purposes only, and does not endorse or guarantee in any way the services or advice provided by them.
